nsc-172755 has been researched along with imatinib mesylate in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Attolou, SGR; Dossou, FM; Gangbo, F; Gbessi, DG; Gbetchedji, PP; Gnangnon, FHR; Imorou Souaïbou, Y; Kpossou, AR; Laleye, MC; Lawani, I; Mehinto, DK; Sehonou, J; Seidou, F | 1 |
1 other study(ies) available for nsc-172755 and imatinib mesylate
| Article | Year |
|---|---|
Challenge of gastro-intestinal stromal tumor management in low-income countries: example of Benin.
Topics: Benin; Cross-Sectional Studies; Female; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Male; Middle Aged; Retrospective Studies | 2022 |